Pharmaids Pharmaceuticals LtdPharmaceuticalsINE117D01018Consolidated₹29.68+0.00 (+0.00%)Dec-25
Valuation
Market Cap₹104.67 Cr
TTM PE-7.57x
Forward PE-7.92x
PEG-1.90
Book Value₹16.82
P/B1.76x
TTM EPS₹-3.92
Fwd EPS₹-3.75
TTM Revenue₹25.47 Cr
TTM PAT₹-15.30 Cr
TTM EBITDA₹-10.20 Cr
TTM EBIT₹-10.42 Cr
Last Qtr PAT₹-2.65 Cr
Last Qtr EBITDA₹-0.87 Cr
Last Qtr EBIT₹-0.93 Cr
Profitability
ROE-25.79%
ROCE4.24%
TTM NPM-60.07%
TTM EBITDA %-40.05%
Curr OPM-48.06%
Last OPM-28.64%
Curr NPM
Last NPM
Curr EPS₹-0.70
Last EPS₹-0.70
Balance sheet
Equity₹35.27 Cr
Reserve₹24.05 Cr
Total Debt₹35.24 Cr
D/E0.59x
Interest %-27.17%
Curr Interest₹0.72 Cr
Price / range
Close₹29.68
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D0.00%
1W-2.08%
1M-10.03%
3M-9.70%
6M-10.66%
1Y-46.37%
2Y-29.03%
3Y-17.83%
5Y+104.69%
Diwali-37.79%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue0-100.0%2.690.835.971.1210.60
Other Income0.050.060.060.190.350.66
Total Income0.05-96.6%2.750.896.161.4611.26
Interest0.570.600.571.021.113.30
Expenditure-1.50+78.9%-4.42-5.13-11.62-7.10-28.33
PBDT000000
EBITDA-0.87+82.0%-1.08-3.68-4.57-4.82-14.22
Depreciation-0.06-0.05-0.05-0.06-0.05-0.21
EBIT-0.93+80.9%-1.13-3.73-4.63-4.87-14.43
PBT2.75-1.69-4.24-2.330-13.95
Tax-0.610.381.130.681.303.52
Equity000000
OPM0.00-62.89-508.76-39.120.00-124.00
Net Profit2.14+149.1%-1.69-3.11-1.65-4.36-10.44
NPM0.00-62.89-373.35-27.69-391.30-93.00
EPS0.61-0.37-0.88-0.470-2.95

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 21-22FY 20-21FY 17-18
Revenue10.60+353.0%2.34+7700.0%0.033.94-53.9%8.550.45
Other Income0.661.020.800.020.030.02
Total Income11.26+235.1%3.36+309.8%0.823.95-54.0%8.580.47
Expenditure-28.33-137.1%-11.95-72.9%-6.91-3.81+55.1%-8.49-0.84
Interest-3.30-2.15-0.33000
PBDT00000-0.37
EBITDA-14.22-95.9%-7.26-14.0%-6.370.14+27.3%0.11-0.39
Depreciation-0.21-0.20-0.18-0.01-0.050
EBIT-14.43-93.4%-7.46-13.9%-6.550.13+116.7%0.06-0.39
PBT-13.95-62.4%-8.59-41.1%-6.090.14+55.6%0.09-0.37
Tax3.521.311.140.010.01-0.02
Equity035.270000
OPM (%)-124.00-255.58-740.004.001.00-81.96
Net Profit-10.44-43.4%-7.28-47.1%-4.950.15+66.7%0.09-0.39
NPM (%)-93.00-216.66-601.004.001.00-85.97
EPS (Rs)-2.950+100.0%-2.180.14+55.6%0.09-1.13
CEPS-2.950-2.180.140.090

Consolidated

16 lines · 6 periods
MetricDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue5.43+15.3%8.616.664.774.7119.45
Other Income0.080.220.040.070.010.10
Total Income5.51+16.7%8.836.704.844.7219.55
Interest0.721.081.201.010.492.09
Expenditure-9.13-4.7%-15.47-13.80-10.30-8.72-36.73
PBDT000000
EBITDA-2.50+13.2%-5.31-5.33-3.90-2.88-12.75
Depreciation-0.48-0.47-0.61-0.62-0.64-2.44
EBIT-2.98+15.3%-5.78-5.94-4.52-3.52-15.19
PBT0+100.0%000-4.01-17.28
Tax1.381.131.800.5013.77
Equity0000035.27
OPM0.000.000.000.00-85.08-88.38
Net Profit-2.65+12.0%-2.53-5.32-4.80-3.01-13.51
NPM-48.06-28.64-79.28-99.19-63.90-69.08
EPS-0.70-27.3%-0.70-1.41-1.11-0.550

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 24-25FY 23-24
Revenue19.45+28.7%15.11
Other Income0.100.88
Total Income19.55+22.3%15.99
Expenditure-36.73-16.2%-31.61
Interest-2.09-1.57
PBDT00
EBITDA-12.75+3.4%-13.20
Depreciation-2.44-1.73
EBIT-15.19-1.7%-14.93
PBT-17.28-10.6%-15.62
Tax3.773.78
Equity35.270
OPM (%)-88.38-97.70
Net Profit-13.51-14.1%-11.84
NPM (%)-69.08-74.07
EPS (Rs)0+100.0%-3.56
CEPS0-3.56

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers